Magnesium Sulphate Versus Dexamethasone With TAP Block for Post-Cesarean Analgesia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorKhyber Teaching Hospital

About this trial

This randomized, double-blind, controlled clinical trial will compare the effectiveness of a single intravenous dose of magnesium sulphate versus dexamethasone as an adjuvant to ultrasound-guided transversus abdominis plane (TAP) block for postoperative pain management after elective cesarean section. Eighty women undergoing elective lower-segment cesarean section under spinal anesthesia will be randomly allocated into two groups of 40 participants each. Group M will receive intravenous magnesium sulphate 50 mg/kg diluted in 100 mL normal saline, while Group D will receive intravenous dexamethasone 8 mg diluted in 100 mL normal saline. The study will assess postoperative pain using the Visual Analog Scale at 2, 4, 8, 12, and 24 hours after surgery, as well as duration of analgesia, rescue analgesic requirement, total tramadol consumption, and adverse effects. The study aims to determine whether either intravenous adjuvant provides more effective and prolonged postoperative analgesia when used with ultrasound-guided TAP block after cesarean section.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women aged 18-40 years.

Undergoing elective lower-segment cesarean section under spinal anesthesia.

American Society of Anesthesiologists (ASA) physical status I or II.

Singleton, full-term pregnancy with gestational age of at least 37 weeks.

Disqualifiers

Known allergy or contraindication to magnesium sulphate, dexamethasone, or local anesthetics.

History of chronic pain disorders or regular use of analgesics or opioids.

Neurological, renal, hepatic, or cardiovascular disease.

Pregnancy complications such as pre-eclampsia, eclampsia, or placenta previa.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Magnesium Sulphate 500 mg

    Drug

    Magnesium sulphate 50 mg/kg diluted in 100 mL normal saline, administered as a single intravenous dose 15 minutes before the ultrasound-guided TAP block.

  • Dexamethasone

    Drug

    Dexamethasone 8 mg diluted in 100 mL normal saline, administered as a single intravenous dose 15 minutes before the ultrasound-guided TAP block.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Magnesium Sulphate GroupExperimental treatment 1 intervention
Group B: Dexamethasone GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Duration of analgesia

Time from administration of the ultrasound-guided TAP block until the participant's first request for rescue analgesia, measured in minutes.

Time frame
From completion of the TAP block until the first request for rescue analgesia, assessed during the first 24 hours after cesarean section.

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: